Class IIFood
Eridanous Greek Style Shortbread Cookies with apricot… recall
Summary
Lidl US TRADING is recalling ERIDANOUS GREEK STYLE Shortbread Cookies with apricot filling and cocoa topping … (food). According to the FDA report, the reason is: The firm discovered that certain units shipped to the U.S. retail stores only has "foreign languages" on the label. Product has undeclared wheat, soy, milk, eggs and tree nut (coconut). The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.
Details from the FDA report
- Product
- ERIDANOUS GREEK STYLE Shortbread Cookies with apricot filling and cocoa topping with coconut sprinkles. Product is packed onto a plastic carton tray with outer paper sleeve, 330 g (weight), UPC: 4056489125846.
- Reason
- The firm discovered that certain units shipped to the U.S. retail stores only has "foreign languages" on the label. Product has undeclared wheat, soy, milk, eggs and tree nut (coconut).
- Lot / code info
- BEST BEFORE: 10/11/2026 LOT NO: 260315
- Quantity
- 200 units
- Distribution
- Product was shipped to the following states: DC, DE, GA, MD, NJ, NY, NC, PA, SC, & VA.
- Recalling company
- Lidl US TRADING, Arlington, VA United States
- Recall started
- July 22, 2026
- FDA report date
- September 2, 2026
- Classification
- Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
- Voluntary / mandated
- Voluntary: Firm initiated
- Status
- Ongoing
- Recall number
- H-1275-2026
What to do
- Check whether you have this product, and compare the lot numbers, codes, or dates on your package with the codes listed above.
- If it matches, stop using it and keep it away from children and pets.
- Contact the recalling company (Lidl US TRADING) or the store where you bought it about returns or refunds.
- If you think the product made you or someone else sick, contact a doctor or pharmacist. In an emergency call 911.
- You can report problems to the FDA via MedWatch.